T0	StudyDesign 12753 12768	cross-sectional
T1	SampleSize 12875 12918	the study populations were relatively small
T2	NoPlaceboGroup 13132 13154	a normal control group
T3	Population 13363 13442	a selection bias because of the admission of patients with less severe symptoms
T4	ConfoundingFactors 13450 13532	neurological improvement in stroke patient could be from other factors than statin
T5	VerySpecificPopulation 13025 13119	sLOX-1 and NO levels might be higher or lower in patients with ICAS than in general population
